Objectives: To elucidate the relationship between renin-angiotensin system and nitric oxide in hypertensive heart failure, we evaluated the effects of long-term treatment with imidapril, an angiotensin-converting enzyme inhibitor, on endothelial-cell nitric oxide synthase (eNOS) and inducible NOS (iNOS) expression in the left ventricle (LV) and its relation to myocardial remodelling in failing heart of Dahl salt-sensitive hypertensive rats (DS) fed a high-salt diet. Methods: In DS rats fed an 8% NaCl diet after the age of 6 weeks, a stage of concentric left ventricular hypertrophy at 11 weeks (DSLVH) was followed by a distinct stage of fatal left ventricular failure with chamber dilatation at 18 weeks (DSCHF). Imidapril (DSCHF-I, n57, 1 mg / kg / day, subdepressor dose) or vehicle (DSCHF-V, n57) were given from DSLVH to DSCHF stage for 7 weeks, and age-matched (18 weeks) Dahl salt-resistant rats fed the same diet were served as control group (DR-C, n57). Results: Markedly increased left ventricular end-diastolic diameter and reduced fractional shortening in DSCHF-V was significantly ameliorated in DSCHF-I using transthoracic echocardiography. The level of eNOS mRNA and protein in the LV was significantly suppressed in DSCHF-V compared with DR-C, and significantly increased in DSCHF-I compared with DR-C and DSCHF-V. The iNOS mRNA and protein and the fibrosis factor expression of type I collagen mRNA were significantly increased in DSCHF-V compared with DR-C, and significantly decreased in DSCHF-I compared with DSCHF-V. DSCHF-V demonstrated a significant increase in wall-to-lumen ratio, perivascular fibrosis, and myocardial fibrosis. These changes in the microvasculature were improved significantly by imidapril. Conclusions: Subdepressor dose of imidapril may ameliorate the endothelial damage not only by inhibiting production of angiotensin II but also by promoting eNOS and inhibiting iNOS mRNA and protein expression in the LV, and this increased eNOS mRNA and protein level may have a role in the improvement of congestive heart failure and myocardial remodelling.
Introduction
other studies have reported that these parameters vary among underlying diseases that caused heart failure [5] , Since nitric oxide (NO), an endothelium-dependent and a consensus has not been obtained. The renin-anvasodilator, was identified by Moncada et al. [1] , many giotensin system is also an important factor involved in studies have reported the importance of NO in circulatory circulatory regulation. Angiotensin II is known to exhibit regulation. With respect to circulatory actions alone, it has cardiotonic actions directly on the myocardium [6, 7] , but also been found that NO not only dilates blood vessels but has been reported to exhibit negative inotropic actions also influences myocardial contractility [2] . Furthermore, indirectly via NO [8] . some studies have indicated that expression [3] and With regard to chronic heart failure, many disease activation [4] of inducible nitric oxide synthase (iNOS) are models have been studied. A hamster cardiomyopathy observed in patients with chronic heart failure. However, model [9] and dog or pig rapid pacing models [10] are known as congestive heart failure models with symptoms *Corresponding author. Tel.: 181-0282-87-2149; fax: 181-0282-86-1596.
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such as pleural fluid, ascites and congestion. Recently, diameter (EDD) and fractional shortening (FS) [11] [12] [13] [14] . In salt-loaded Dahl salt-sensitive (DS) rats were reported as a DS rats fed an 8% NaCl diet after the age of 6 weeks, a model that can be used relatively easily [11] [12] [13] [14] . It has stage of concentric left ventricular hypertrophy at 11 been shown that DS rats develop cardiac hypertrophy at 11 weeks (DSLVH) is followed by a distinct stage of fatal left weeks of age and fatal heart failure with cardiac enlargeventricular failure with chamber dilatation at 18 weeks ment at 18 weeks of age when food containing 8% NaCl is (DSCHF). Imidapril (DSCHF-I, n57, 1 mg / kg / day, subgiven from 6 weeks of age. This model can be studied with depressor dose, Tanabe Seiyaku Co., Ltd) or vehicle respect to individual stages, since the reproducibility of (DSCHF-V, n57) were given from the DSLVH to DSCHF deterioration of the condition is good.
stage in drinking water for 7 weeks, and age-matched DR As described above, changes in nitric oxide synthase rats (DR-C, 18 weeks, n57) fed the same diet were served (NOS) are observed in patients with chronic heart failure as a control group. Fourteen DS rats at the stage of [3] [4] [5] . Chronic angiotensin-converting enzyme (ACE) DSLVH were divided into two groups (DSCHF-V and inhibitor has been demonstrated to have favorable effects DSCHF-I) randomly (protocol 1). Experimental designs of on left ventricular function and survival in patients with protocol 2 and 3 were treated in the same manner as congestive heart failure. The institution of ACE inhibitor described above in protocol 1. has been shown to improve left ventricular geometry, loading conditions, and neurohormonal status in both 2.2. Protocol 1 humans and animals with developing congestive heart failure [15, 16] . Furthermore, it is known that ACE in-2.2.1. Reverse transcription-polymerase chain reaction hibitors reduce the formation of angiotensin II and prevent (RT-PCR) the degradation of bradykinin [17] , an endothelium-depenAfter 7 weeks of treatment, the rats were anesthetized dent relaxant that works by stimulating the release of NO with sodium pentobarbital (50 mg / kg IP) and decapitated, [18] . However, very few studies have evaluated whether and the heart was immediately excised. The left ventricle the beneficial effects of ACE inhibitors on myocardial was carefully separated from the atria and right ventricle, remodelling is associated with direct local gene expression weighed, immediately frozen in liquid nitrogen, and stored of endothelial-cell NOS (eNOS) and iNOS mRNA and at 2808C until extraction of total RNA. Total RNA was protein in failing heart of DS rats. The purpose of the prepared as previously described [22] . [26] , using a DNA PCR kit (Perkin-Elmer, obtained from Brookhaven National Laboratories, Upton, Norwalk, CT, USA) for 30 cycles of denaturation at 958C New York, were bred and supplied by Eisai Co., Ltd.
for 30 s, annealing at 558C for 30 s, and elongation at 728C (Tokyo, Japan) [19, 20] . After they were weaned, the rats for 1 min. Parallel amplification of rat glyceraldehyde-3-were fed a diet containing 0.3% NaCl until the age of 6 phosphate dehydrogenase (GAPDH) was performed for weeks. Thereafter, they were fed a diet containing 8% reference with primers as described [27] . Reaction conNaCl. The rats were weighed, and their systolic blood ditions were optimized to obtain reproducible and reliable pressure (SBP) was measured by the tail-cuff method amplification within the logarithmic phase of the reaction, (Muromachi Kikai, model MK-1100, Tokyo, Japan) before as determined by preliminary experiments. The reaction feeding with the 8% NaCl diet and at 1-week intervals was linear to 35 cycles with use of the ethidium bromide thereafter. Transthoracic echocardiography (model SSAdetection method. PCR products were separated by electro-260A, Toshiba, Tokyo, Japan, with a 7.0 / 5.0-MHz micro phoresis on a 2% agarose gel containing ethidium bromide probes, PVF-738H, Tokyo, Japan) was performed as and were visualized by ultraviolet-induced fluorescence. described [11] [12] [13] [14] 21 ] on the day before the rats were
The intensity of each band was quantified using a densikilled. We determined the left ventricular end-diastolic tometer. The resulting densities of the eNOS, iNOS, and type I collagen bands were expressed relative to the of the vessels were made on the screen of a multiscan corresponding densities of the GAPDH bands from the color computer display (Sony, model CPD-17SF7, Tokyo, same RNA sample [28] [29] [30] . Japan) and then digitized with a two-dimensional analysis system (Mac SCOPE, Mitani Corporation, Japan) con-2.3. Protocol 2 nected with a Macintosh computer system (Power Macintosh G3, Apple Computer Inc.). Histopathological findings 2.3.1. Western blot analysis of the myocardium and coronary arterioles were examined. We always measured the capillary density and cross-2.3.1.1. Tissue preparation. LV was homogenized (25% sectional surface area in the endocardium of the posterior w / v) in 10 mmol / l HEPES buffer, pH 7.4, containing 320 portion of the left ventricular free wall. In this part of the mmol / l sucrose, 1 mmol / l EDTA, 1 mmol / l DTT, 10 heart, shrinkage was minimal and orientation of the mg / ml leupeptin, and 2 mg / ml aprotinin at 0 to 48C with a myocardial fibres was similar from one heart to another. polytron homogenizer. Homogenate was centrifuged at
We analyzed five sites from each ventricle in all rats. To 10003g for 5 min at 48C and the resulting supernatant was assess thickening of the coronary arterial wall and used as a post-nuclear fraction. Protein concentrations perivascular fibrosis, the transectional images of the area of 4 2 were determined with bovine serum albumin as a standard the total small arteriolar lumen #10 mm were studied. protein [31] .
The inner border of the lumen and the outer border of the tunica media were traced in each arterial image with 2.3.1.2. Western blotting. The post-nuclear fraction hematoxylin-eosin staining at 3100 to 3400 magnifica-(eNOS: 50 mg of protein, iNOS: 200 mg of protein) of each tion, and the areas encircled by the tracings were calcusample was subjected to SDS-PAGE using 10% gels [32] .
lated. In quantification, nonround vessels resulting from The proteins in the gels were transferred electrophoreticaloblique transection or branching were excluded, and only 2 ly to PVDF sheets for 1 h at 2 mA / cm as described [33] . round vessels were studied. The wall-to-lumen ratio (the The sheets were immunoblotted with an anti-eNOS or area of the vessel wall divided by the area of the total anti-Mac NOS antibody (Transduction Laboratories, antiblood vessel lumen) was determined. The area of fibrosis eNOS: N30020, anti-Mac NOS: N39120) in a buffer immediately surrounding blood vessels was calculated, and containing 10 mmol / l Tris / HCl, pH 7.5, 100 mmol / l perivascular fibrosis was determined as the ratio of the area NaCl, 0.1% Tween 20, and 5% skim milk followed by of fibrosis surrounding the vessel wall to the total area of peroxidase-conjugated goat anti-mouse IgG (Amersham the vessel. To assess the area of myocardial fibrosis, the Life Science Inc.) [33] . The eNOS and iNOS proteins area of pathological collagen deposition was measured in transferred to the sheets were detected using the ECL the microscopic field of each Masson's trichrome-stained immunoblotting detection system (Amersham Life Science section. The ratio of the total area of fibrosis within the left Inc.). The amount of each protein was quantified using a ventricular myocardium to the total area of the left densitometer in a linear range and expressed as percent ventricular myocardium in each heart was calculated and relative to that in the non-treated rat.
was used for analysis. The histopathology on the sections from each rat was carried out by an operator who was 2.4. Protocol 3 blinded to the treatment groups.
Histologic examination and evaluation of myocar-2.5. Statistical analysis dial remodelling
Histological examination was studied as described in All results are expressed as mean6SEM. The mean detail previously [29, 30, 34] . Briefly, excised hearts were values were compared among the three groups using perfused with physiological saline solution containing ANOVA followed by the Bonferroni test. Differences of adenosine 10 mg / kg and nitroglycerin 10 mg / kg and then P,0.05 were considered statistically significant. Calculawith 6% formaldehyde solution via retrograde infusion into tions, including those of derived values, and statistical the ascending aorta at a pressure of 90 mm Hg. The LV tests, were performed using the appropriate software (Stat was separated from the right ventricle, the atria, and the View-J 4.5, Abacus Concepts Inc., CA, USA) and a Power great vessels, and cut into five pieces perpendicular to the Macintosh computer system (G3, Apple Computer Inc.). long axis. For light microscopy, 1.5-mm-thick sections were cut (microtome, Tokyo, Japan). Paraffin slices from each heart were mounted on glass slides and stained with 3. Results hematoxylin-eosin and Masson's trichrome stains. All histopathological sections of each animal were examined 3.1. Systemic hemodynamics, body weight, and left using a 3CCD color video camera (Sony, model DXC-930, ventricular weight Tokyo, Japan) mounted on a standard microscope (Olympus, BHS-F, Tokyo, Japan). Drawings of the limits As shown in Table 1 , SBP in DSCHF-V and DSCHF-I was similar and significantly higher than that in DR-C. DSCHF-I than in DSCHF-V (0.3660.02, vs. DSCHF-V, Heart rate was similar in DR-C and DSCHF-V, and was not P,0.01) (Figs. 2 and 3C ). 
Left ventricular EDD and FS
Left ventricular EDD in DSCHF-V was significantly increased compared with DR-C (9.4460.38 vs. 7.4060.07 mm, P,0.01), and significantly decreased in DSCHF-I compared with DSCHF-V (7.5960.26 mm, vs. DSCHF-V, P,0.01) (Fig. 1A) . Left ventricular FS in DSCHF-V was significantly decreased compared with DR-C (25.2060.73 vs. 42.2660.81%, P,0.01), and significantly increased in DSCHF-I compared with DSCHF-V (38.4761.39%, vs. DSCHF-V, P,0.01) (Fig. 1B). 
RT-PCR for eNOS, iNOS, and type I collagen mRNA expression in the LV
The level of eNOS mRNA in the LV was significantly decreased in DSCHF-V compared with DR-C (0.2160.02 vs. 0.3560.01, eNOS mRNA / GAPDH mRNA, P,0.01), and significantly increased in DSCHF-I compared with DR-C and DSCHF-V (0.5360.05 vs. DR-C and DSCHF-V, P,0.01, respectively) (Figs. 2 and 3A) . The level of iNOS mRNA was significantly increased in DSCHF-V compared GAPDH mRNA, P,0.01), and was significantly less in DSCHF-V. (Figs. 4 and 5B). These results were almost consistent with those obtained by RT-PCR analysis.
Myocardial remodelling
The wall-to-lumen ratio increased in DSCHF-V compared with DR-C (0.3760.01 vs. 0.1360.01, P,0.01) and significantly decreased by imidapril treatment (0.2160.01, vs. DSCHF-V, P,0.01) (Fig. 6A) . The degree of perivascular fibrosis was significantly greater in DSCHF-V than in DR-C (0.7660.03 vs. 0.2460.02, P,0.01), and was also significantly decreased by imidapril treatment (0.4760.02, vs. DSCHF-V, P,0.01) (Fig. 6B ). Compared (Fig. 6C). iNOS (B), and type I collagen (C) bands in relation to the bands obtained for GAPDH. Values are expressed as means6SEM. DR-C, Dahl saltresistant rats (control group); DSCHF-V, failing heart of Dahl saltsensitive hypertensive rats treated with vehicle; DSCHF-I, failing heart of
Discussion
Dahl salt-sensitive hypertensive rats treated with imidapril, n57 per † group. *P,0.01 vs. DR-C, P,0.01 vs. DSCHF-V.
In the myocardium of patients with dilated cardiomyopathy-derived chronic heart failure, reduced eNOS activity and increased iNOS activity have been reported ing diseases that caused heart failure, iNOS mRNA was [4] . Furthermore, in the myocardium of patients with detected in failing heart from septic patients but not in dilated cardiomyopathy, ischemic heart disease or valvular those from patients with idiopathic dilated cardiomyopathy heart disease-derived chronic heart failure, it has also been and ischemic heart disease [5] . To examine this issue, we shown that iNOS mRNA expression is enhanced [3] .
used the failing heart of salt-loaded DS rats in which the However, iNOS mRNA expression varies among underlycontractility of the left ventricular myocardium decreased in vivo during the transition from the compensated left ventricular hypertrophy stage to the failing stage during a specific period [11] [12] [13] [14] . In this model, left ventricular eNOS mRNA and protein expression was reduced, while iNOS mRNA and protein expression was increased. In the myocardium of normal rats, eNOS is mainly detected, but iNOS can not be detected and be induced by endotoxin shock [35] . In isolated myocardial cells, it has also been reported that iNOS is induced by cytokine stimuli [36] . It is speculated that iNOS expression induces excessive and continuous release of NO, causing various myocardial patients. Therefore, the decreases in left ventricular eNOS mRNA and protein expression and increases in iNOS In the present study, total RNA was assayed by RT-PCR mRNA and protein expression observed in our model may with gene-specific primers for eNOS and iNOS. The be involved in the onset and deterioration of heart failure results of the RT-PCR showed that eNOS was significantly in this model. suppressed and the iNOS mRNA level was significantly Imidapril treatment improved the decreases in left increased in DSCHF-V compared with DR-C. In addition, ventricular eNOS mRNA and protein expression in the eNOS was significantly increased and the iNOS mRNA DSCHF-V group. The value was increased even when level was significantly decreased in DSCHF-I compared compared to that in the DR-C group. On the other hand, with DSCHF-V. Furthermore, the monoclonal antibodies imidapril treatment significantly inhibited enhancement of used for Western blot analysis detect both the eNOS and left ventricular iNOS mRNA and protein expression in the iNOS. The results of the Western blot analysis were almost DSCHF-V group. The effects of bradykinin on left venconsistent with those obtained by RT-PCR. Therefore, it is tricular eNOS and iNOS expression are unclear. However, important to assess NOS expression at both the mRNA and angiotensin II has been reported to enhance cytokineprotein levels to determine the contribution of regulation of stimulated iNOS mRNA expression in rat isolated myocarthe eNOS and iNOS at the level of gene transcription as dial cells [38] . Therefore, ACE inhibitors may normalize well as at the level of protein expression. the NO system of the myocardium via inhibitory effects on ACE inhibitors are prescribed as the first-choice drug for the renin-angiotensin system at local myocardial sites. chronic heart failure. It has been reported that these agents Antihypertensive therapy improves endothelial function not only exhibit life-prolonging effects [50, 51] but also in different models of hypertension [39, 40] , and ACE improve ejection fraction [52] and exercise tolerance [53] inhibitors appear to be particularly effective in hypertenwhen administered for a long period. In this study, sive rats [39, 40] . It is known that ACE inhibitors reduce imidapril [54, 55] , of which the efficacy has been demonthe formation of angiotensin II and inhibit the bradykinin strated in various heart failure models, was administered to breakdown [41] and may have an effect on the suppression salt-loaded DS rats for a long period. As a result, this of kininase II, which inactivates bradykinin, a stimulator of treatment significantly inhibited increased end-diastolic NO release [42, 43] . The increase in bradykinin concendimension and decreased fractional shortening in the tration resulting from inhibition of its breakdown by ACE DSCHF-V group. Furthermore, morphologically, this treatinhibitor would increase NOS via stimulation of the ment inhibited not only increased heart weight and vascubradykinin B2 receptor subtype and therefore may contriblar thickening but also myocardial interstitial fibrosis, ute to the inhibition of vascular and myocardial structural perivascular fibrosis and type I collagen mRNA expreschanges [44] . There is some evidence that local tissue sion. Several mechanisms may be involved in the benefirenin-angiotensin systems may be involved in myocardial cial effects of imidapril on cardiac structure and function fibrosis. Angiotensin II was found to stimulate cardiac in failing heart of salt-loaded DS rats. The first, the growth [45] , and collagen synthesis in cultured vascular mechanism by which subdepressor dose of imidapril smooth muscle cells [46] and to increase fibroblast prolifimproves heart failure should involve inhibition of the eration and growth of cardiomyocytes [47] . Therefore, renin-angiotensin system, independent of systolic blood angiotensin II may play an important role in cardiac pressure. The second, it is generally known that ACE collagen gene expression and may be responsible for inhibitors inhibit degradation of bradykinin. Bradykinin myocardial fibrosis. On the other hand, Ishigai et al. [48] has been reported to improve cardiac function [56] and demonstrated that bradykinin inhibits the progression of inhibit fibrosis [57] . Therefore, pathological and functional cardiac hypertrophy due to the increase in NO release and improvement via bradykinin cannot be denied, but the that perindoprilat produces beneficial effects on cardiac association of changes in myocardial eNOS and iNOS hypertrophy by stimulating the bradykinin-NO pathway in mRNA and protein with bradykinin should be further rat cultured heart cells. Furthermore, Hartman [49] indiexamined. In any case, improvement in cardiac function by cated that the in vivo cardioprotective effect of ramiprilat imidapril and the inhibitory effects of imidapril on recan be abolished by antagonizing bradykinin receptors or modelling noted in the salt-loaded DS heart failure model inhibiting NOS, and that the effect is not related to we used may have been related to inhibition of the reninangiotensin II receptor activity. The potential bradykininangiotensin system at local myocardial sites and / or inhibsparing property of ramiprilat may promote increased itory effects on bradykinin degradation. bradykinin-stimulated NO production leading to cardioIn conclusion, subdepressor dose of imidapril may protection. Part of the cardioprotective effects of ramiameliorate the endothelial damage not only by the inhibprilat / bradykinin / NO may occur locally as demonstrated iting production of angiotensin II but also by the promotby the in vitro results using isolated cardiomyocytes.
ing eNOS and inhibiting iNOS mRNA and protein expresTherefore, endogenously bradykinin-NO pathway may sion in the LV, and this increased eNOS mRNA and protein participate in the antihypertrophic property of ACE inlevel may have a role in the improvement of congestive hibitors in heart failure.
heart failure and myocardial remodelling.
enzyme inhibition prolongs survival and modifies the transition to
